BIT Biotech Opportunities I-II Fonds
113,84
EUR
-1,37
EUR
-1,19
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Scholar Rock Holding Corp | US80706P1030 | 5,97% |
| Viking Therapeutics Inc | US92686J1060 | 4,93% |
| Day One Biopharmaceuticals Inc | US23954D1090 | 3,84% |
| Viridian Therapeutics Inc | US92790C1045 | 3,63% |
| Blueprint Medicines Corp | US09627Y1091 | 3,51% |
| Syndax Pharmaceuticals Inc | US87164F1057 | 3,24% |
| IDEAYA Biosciences Inc | US45166A1025 | 3,24% |
| Ascendis Pharma AS ADR | US04351P1012 | 3,20% |
| argenx SE ADR | US04016X1019 | 3,20% |
| SpringWorks Therapeutics Inc Ordinary Shares | US85205L1070 | 3,17% |
| Sonstige | 62,05% |